AT-406 (SM-406, ARRY-334543)

Catalog No. A11163

AT-406 (SM-406,ARRY-334543)是IAP家族蛋白质的口服生物利用抑制剂,具有潜在的凋亡诱导和抗肿瘤活性。AT-406选择性抑制IAP蛋白的生物学活性,包括X染色体连锁IAP(XIAP),细胞IAP 1(c-IAP1)和2(c-IAP2)和黑色素瘤凋亡抑制蛋白(ML-IAP)。
  • Yoshikawa M, .et al. Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships, J Med Chem, 2018, Mar 22;61(6):2384-2409 PMID: 29485864
  • Tsuyoshi Ishii, .et al. CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens, Sci Rep, 2017, 7: 13000 PMID: 29026104
Catalog Num A11163
M. Wt 561.71
Formula C32H43N5O4
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1071992-99-8
Synonyms AT406, SM-406, ARRY-334543
SMILES C[C@@H](C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)CC(C)C)NC
AT-406 (SM-406,ARRY-334543)是IAP家族蛋白质的口服生物利用抑制剂,具有潜在的凋亡诱导和抗肿瘤活性。AT-406选择性抑制IAP蛋白的生物学活性,包括X染色体连锁IAP(XIAP),细胞IAP 1(c-IAP1)和2(c-IAP2)和黑色素瘤凋亡抑制蛋白(ML-IAP)。
In vitro (25°C) DMSO 85 mg/mL (151.32 mM)
Water Insoluble
Ethanol 85 mg/mL (151.32 mM)
In vivo 30% propylene glycol, 5% Tween 80, 65% D5W 28 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 17.8 mL 89.01 mL 178.03 mL
0.5 mM 3.56 mL 17.8 mL 35.61 mL
1 mM 1.78 mL 8.9 mL 17.8 mL
5 mM 0.36 mL 1.78 mL 3.56 mL

*The above data is based on the productmolecular weight 561.71. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.